The Latest
-
Florida seeks to eliminate vaccine mandates, including for children
State Surgeon General Joseph Ladapo says the state health department can abolish some vaccine requirements while others need lawmakers’ approval.
-
Sponsored by Oracle
Marshall Health Network’s chief population health officer talks data, value-based care and new opportunities with AI
Data Intelligence is enabling Marshall Health to enhance primary care advocacy across its communities.
-
CMS tweaks AHEAD all-payer model for states
The model will now run for one additional year and require providers to assume more downside risk.
-
Over 1,000 HHS workers call for RFK Jr. to step down
The letter cites turmoil at the CDC, which is reeling from the firing of Director Susan Monarez and the departure of at least four high-level leaders last week.
-
DOJ sues ProMedica Health for ‘non-existent, grossly substandard’ care at nursing homes
The government alleges executives at ProMedica pressured four facilities to increase admissions and cut staffing, even while patient care deteriorated.
-
Medicare saved record $2.4B from largest accountable care program last year
ACOs are also improving in quality, according to the CMS data. Still, the Medicare Shared Savings Program has struggled with waning provider buy-in.
-
Cigna’s Evernorth invests $3.5B in ex-Walgreens specialty pharmacy
The investment in Shields Health Solutions gives Evernorth greater reach into specialty pharmacy services for providers, which Cigna’s COO has called an “important addressable market expansion opportunity.”
-
AI devices with no clinical validation tied to more recalls, study finds
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.
-
CDC panel to discuss COVID, hepatitis B shots in September meeting
A federal register notice confirmed dates for the anticipated advisory meeting, which will follow an FDA decision to narrow COVID boosters' approval and comes as CDC leadership is in turmoil.
-
Top healthcare legislation to watch so far this year
Federal lawmakers have proposed dozens of bills targeting core healthcare issues, including 340B, Medicaid, AI and site-neutral payments.
-
CVS agrees to pay Massachusetts $12M to settle Medicaid overbilling claims
The retail pharmacy giant has also agreed to annually review its practices to ensure the state’s Medicaid program is getting the lowest possible prices for prescription drugs.
-
Sycamore Partners closes Walgreens acquisition, splits retailer into 5 companies
The deal’s closure also comes with a raft of leadership changes. Mike Motz, the former CEO of Staples U.S. Retail, has been appointed as Walgreens CEO effective immediately.
-
Tracker
The Trump administration is overhauling healthcare policy. Follow the changes here.
HHS said it has removed Susan Monarez as director of the Centers for Disease Control and Prevention, a month after she was confirmed by the Senate. Monarez’s attorney claims the firing was invalid.
Updated Aug. 28, 2025 -
AI has promise, but health executives struggle with safe adoption: survey
Only 13% of health system leaders agreed that their organization had a clear strategy for integrating AI, according to a survey from consultancy Sage Growth Partners.
-
Medicare Advantage plans frequently deny post-acute care for nursing homes, survey finds
The findings build on other research suggesting that MA insurers restrict care more than they should, especially post-acute services.
-
Surprise Billing
No Surprises dispute resolution is creating billions of dollars in extra costs, could raise premiums: analysis
Providers are turning to the law’s arbitration process in droves to settle out-of-network claims, one factor fueling spending that could cost consumers down the line.
-
Physicians say fewer qualified doctors apply for jobs: report
In a new report from Medscape, physicians say a lack of qualified applicants is hampering efforts to fill open positions. Many worry the situation could get worse over the next decade.
-
Deep Dive
A $50B rural health fund was negotiated with hospitals in mind. Experts are split on whether it will help them at all.
The fund was created to help Republicans secure critical votes for their reconciliation bill. But experts aren't quite sure how it'll work, creating a $50 billion dollar question with major ramifications for rural hospitals.
-
AdvaMed urges Dr. Oz to speed Medicare coverage of breakthrough devices
The trade group wants the CMS to take “bold action” to cut the lag between FDA authorization of devices and Medicare coverage.
-
Blue Shield of California names interim CEO to permanent chief executive
Mike Stuart has been the California Blues giant’s interim CEO since March. Now, he’s officially stepping into the role.
-
Johns Hopkins goes out of network with UnitedHealthcare after failed contract negotiations
The Baltimore-based system and the major insurer failed to resolve their contract spat by Monday’s deadline, sending some 60,000 patients out of network. Both pledged to continue negotiations.
-
Supreme Court allows NIH to axe millions of research funds related to DEI
The Thursday ruling allows the National Institutes of Health to cut nearly $800 million of research funds for studies like HIV prevention.
-
ModivCare files for bankruptcy with over $1.4B in debt
The medical transportation firm blamed mounting headwinds for its financial challenges, including labor cost inflation and declining reimbursements from public payers.
-
Judge stays provisions of Trump administration rule overhauling ACA
A Maryland district judge has paused heightened standards for people verifying their eligibility for subsidies and other key elements of a controversial final rule from July.
-
Oracle Health’s market share declined ‘substantially’ after Cerner buy: report
The company has lost 57 unique acute care customers in the past three years, 12 of which are larger health systems, according to Klas Research.
-
Judge approves $2.8B Blues settlement with providers
The final settlement wraps up 12 years of litigation over Blue Cross and Blue Shield plans’ alleged collusion to lower reimbursement to U.S. providers.